InvestorsHub Logo
Followers 91
Posts 11357
Boards Moderated 0
Alias Born 06/06/2014

Re: OFP post# 229446

Thursday, 01/09/2020 10:44:19 AM

Thursday, January 09, 2020 10:44:19 AM

Post# of 462982
Apparently the OPC assay study with Biogen in early 2017 wasn't successful since there was no follow up in vivo remylenation study, the path the company envisioned. Anyway the just-granted patent we applied for a couple years ago does cover Rett Syndrome treatment, which we will soon get top line results on.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News